Breaking News Instant updates and real-time market news.

BKR

Baker Hughes

$22.64 /

-0.025 (-0.11%)

13:07
01/08/21
01/08
13:07
01/08/21
13:07

Baker Hughes reports U.S. rig count up 9 to 360 rigs

Baker Hughes reports that the U.S. rig count is up 9 from last week to 360 with oil rigs up 8 to 275, gas rigs up 1 to 84, and miscellaneous rigs unchanged at 1. The U.S. Rig Count is down 421 rigs from last year's count of 781, with oil rigs down 384, gas rigs down 35 and miscellaneous rigs down 2. The U.S. Offshore Rig Count is unchanged at 17, down 4 year-over-year. The Canada Rig Count is up 58 from last week to 117, with oil rigs up 35 to 53, gas rigs up 23 to 64. The Canada Rig Count is down 86 rigs from last year's count of 203, with oil rigs down 67, gas rigs down 19.

  • 21

    Jan

BKR Baker Hughes
$22.64 /

-0.025 (-0.11%)

01/08/21 Barclays
Baker Hughes downgraded to Equal Weight from Overweight at Barclays
12/18/20 JPMorgan
Baker Hughes price target raised to $23 from $20 at JPMorgan
12/15/20 Citi
Baker Hughes downgraded to Neutral from Buy at Citi
12/10/20 HSBC
Baker Hughes downgraded to Hold from Buy at HSBC

TODAY'S FREE FLY STORIES

Hot Stocks
GeoPark responds to letter from former Chair Gerald O'Shaughnessy » 18:05
06/18/21
06/18
18:05
06/18/21
18:05
GPRK

GeoPark

$13.49 /

-0.36 (-2.60%)

GeoPark issued the…

GeoPark issued the following statement in response to the letter sent to the Board by its former Chair Gerald O'Shaughnessy: "Since GeoPark's inception, we have always worked to ensure we have the skills, capabilities and necessary tools to become the leading independent E&P Company in Latin America. As we have grown and matured, we have worked deliberately to strengthen our governance profile and, today, our Board has a majority of independent directors and a newly appointed independent chair, consistent with best practices. We have added two new independent directors in the last 12 months and have nominated a third independent director for election at the upcoming Annual General Meeting. We have also instituted a new Board committee with two independent members to oversee strategic matters. Our Board's continued evolution and diversification in recent years is an important and notable achievement, and one that we expect will help us build and deliver value to all shareholders. It is unfortunate that, after 18 years of service as the Chair of GeoPark's Board, Mr. O'Shaughnessy, 72, has chosen to leave the Board and disparage GeoPark with baseless claims. The Board and the management team are focused on the best interests of the company and our shareholders. We maintain an open dialogue with our shareholders and are always open to opportunities that will create value for all shareholders."

ShowHide Related Items >><<
GPRK GeoPark
$13.49 /

-0.36 (-2.60%)

GPRK GeoPark
$13.49 /

-0.36 (-2.60%)

03/11/21 BMO Capital
GeoPark price target raised to $20 from $15 at BMO Capital
09/24/20 JPMorgan
GeoPark initiated with an Overweight at JPMorgan
06/25/20 Bradesco BBI
GeoPark initiated with an Outperform at Bradesco BBI
Hot Stocks
Newater Technology announces discharge of injunction against going private deal » 18:02
06/18/21
06/18
18:02
06/18/21
18:02
NEWA

Newater Technology

$3.26 /

-0.07 (-2.10%)

Newater Technology…

Newater Technology announced that on June 17, the Commercial Division of the Eastern Caribbean Supreme Court in the British Virgin Islands discharged an injunction that had been obtained on March 16 on an ex parte basis by Fulcan Capital Partners. Fulcan had sought to prevent the company, the members of the board of directors, and Tigerwind Group from taking any steps to proceed with the proposed "going private" merger transaction. In response to the ex parte order, the company applied to discharge the injunction on the basis that Fulcan had breached its duty of full and frank disclosure when applying for the injunction. In discharging the injunction with immediate effect, the BVI Court accepted the company's submissions that the Court had been misled by Fulcan at the ex parte hearing on March 16. In response to the BVI Court's order, Yuebiao Li said, "Although it's too bad that we had to divert precious time and resources to fight this baseless lawsuit, we're glad to have this ex parte injunction behind us."

ShowHide Related Items >><<
NEWA Newater Technology
$3.26 /

-0.07 (-2.10%)

Conference/Events
Vir Biotechnology to host conference call » 17:45
06/18/21
06/18
17:45
06/18/21
17:45
VIR

Vir Biotechnology

$46.11 /

+2.24 (+5.11%)

Management discusses the…

Management discusses the new data on Hepatitis B being presented at the European Association for the Study of the Liver (EASL) Digital International Liver Congress on a conference call to be held on June 25 at 11 am. Webcast Link

ShowHide Related Items >><<
VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

06/03/21 Baird
Vir Biotechnology assumed with a Neutral at Baird
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
03/08/21 H.C. Wainwright
Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
  • 08
    Jul
VIR Vir Biotechnology
$46.11 /

+2.24 (+5.11%)

Conference/Events
Chemours to hold an investor webinar » 17:39
06/18/21
06/18
17:39
06/18/21
17:39
CC

Chemours

$32.85 /

-1.355 (-3.96%)

Management holds an…

Management holds an Advanced Performance Materials Investor Webinar on June 28 at 10 am. Webcast Link

ShowHide Related Items >><<
CC Chemours
$32.85 /

-1.355 (-3.96%)

CC Chemours
$32.85 /

-1.355 (-3.96%)

06/09/21 Wolfe Research
Chemours initiated with an Outperform at Wolfe Research
06/09/21
Fly Intel: Top five analyst upgrades
06/09/21 Goldman Sachs
Chemours upgraded to Buy from Neutral at Goldman Sachs
05/20/21 BofA
BofA starts Chemours at Buy with $42 price target
CC Chemours
$32.85 /

-1.355 (-3.96%)

CC Chemours
$32.85 /

-1.355 (-3.96%)

CC Chemours
$32.85 /

-1.355 (-3.96%)

Conference/Events
Gol Linhas to hold a conference call » 17:34
06/18/21
06/18
17:34
06/18/21
17:34
GOL

Gol Linhas

$9.83 /

+0.015 (+0.15%)

Conference call to…

Conference call to discuss the future of flying in 2021 will be held on June 24 at 2:30 pm. Webcast Link

ShowHide Related Items >><<
GOL Gol Linhas
$9.83 /

+0.015 (+0.15%)

GOL Gol Linhas
$9.83 /

+0.015 (+0.15%)

06/14/21 HSBC
Gol Linhas price target raised to R$26 from R$25 at HSBC
05/05/21 HSBC
Gol Linhas downgraded to Hold from Buy at HSBC
04/11/21 Goldman Sachs
Gol Linhas price target lowered to $9.85 from $11.05 at Goldman Sachs
04/01/21 Itau BBA
Gol Linhas initiated with a Market Perform at Itau BBA
GOL Gol Linhas
$9.83 /

+0.015 (+0.15%)

GOL Gol Linhas
$9.83 /

+0.015 (+0.15%)

Conference/Events
CytoDyn to hold a pharmaceutical update conference call » 17:27
06/18/21
06/18
17:27
06/18/21
17:27
CYDY

CytoDyn

$1.89 /

+0.09 (+5.00%)

President & CEO…

President & CEO Pourhassan, Chairman & CMO Kelly and COO Recknor discuss the results from the unblinded data from COVID-19 long-haulers trial and other regulatory advancements on a conference call to be held on June 21 at 4 pm. Webcast Link

ShowHide Related Items >><<
CYDY CytoDyn
$1.89 /

+0.09 (+5.00%)

CYDY CytoDyn
$1.89 /

+0.09 (+5.00%)

04/06/21
CytoDyn to host conference call
07/06/20 H.C. Wainwright
CytoDyn downgraded to Neutral from Buy at H.C. Wainwright
Conference/Events
Cisco participates in a conference call with Oppenheimer » 17:18
06/18/21
06/18
17:18
06/18/21
17:18
CSCO

Cisco

$52.07 /

-1.065 (-2.00%)

Conference call with SVP…

Conference call with SVP Patel to discuss Cisco's collaboration business, portfolio and competitive advantages will be held on June 24 at 11 am hosted by Oppenheimer.

ShowHide Related Items >><<
CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

05/21/21
Fly Intel: Top five analyst downgrades
05/21/21 DZ Bank
Cisco downgraded to Hold from Buy at DZ Bank
05/20/21 Morgan Stanley
Cisco tone on growth runway leaves Morgan Stanley confident
05/20/21 Oppenheimer
Cisco price target raised to $55 from $50 at Oppenheimer
CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

Conference/Events
Cisco participates in a conference call with Goldman Sachs » 17:10
06/18/21
06/18
17:10
06/18/21
17:10
CSCO

Cisco

$52.07 /

-1.065 (-2.00%)

Management discusses the…

Management discusses the ESG Agenda for 2021 on a conference call to be held on June 22 at 11 am with Goldman Sachs. Webcast Link

ShowHide Related Items >><<
CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

05/21/21
Fly Intel: Top five analyst downgrades
05/21/21 DZ Bank
Cisco downgraded to Hold from Buy at DZ Bank
05/20/21 Morgan Stanley
Cisco tone on growth runway leaves Morgan Stanley confident
05/20/21 Oppenheimer
Cisco price target raised to $55 from $50 at Oppenheimer
CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

CSCO Cisco
$52.07 /

-1.065 (-2.00%)

Hot Stocks
Climate Change Crisis Real Impact I to transfer listing to Nasdaq from NYSE » 17:02
06/18/21
06/18
17:02
06/18/21
17:02
CLII

Climate Change Crisis Real Impact I

$13.99 /

-0.1 (-0.71%)

Climate Change Crisis…

Climate Change Crisis Real Impact I Acquisition Corporation announced that it intends to voluntarily transfer the listing of its shares of Class A common stock and its warrants to The Nasdaq Global Select Market from the New York Stock Exchange following the completion of its previously announced business combination with EVgo Services, which is expected to close on or around July 1, pending approval by stockholders of CLII at its special meeting for stockholders on June 29. In connection with the closing of the business combination, CLII will change its corporate name to "EVgo Inc." CLII expects its Class A common stock and warrants to commence trading on Nasdaq the day after the closing of the business combination under the symbols "EVGO" and "EVGOW," respectively. The Class A common stock and warrants will continue to trade on the NYSE until the transfer to Nasdaq is complete. The decision to list on Nasdaq was made in connection with the business combination and enables the post-combination company to be listed alongside similar companies that are also listed on Nasdaq. At the closing of the business combination, CLII will also delist its units, Class A common stock and warrants from the NYSE. The Nasdaq listing of the Class A common stock and warrants and the NYSE delisting of the units are subject to the closing of the business combination and the fulfillment of all Nasdaq listing requirements.

ShowHide Related Items >><<
CLII Climate Change Crisis Real Impact I
$13.99 /

-0.1 (-0.71%)

CLII Climate Change Crisis Real Impact I
$13.99 /

-0.1 (-0.71%)

CLII Climate Change Crisis Real Impact I
$13.99 /

-0.1 (-0.71%)

CLII Climate Change Crisis Real Impact I
$13.99 /

-0.1 (-0.71%)

Hot Stocks
BeiGene announces China NMPA approval of BRUKINSA » 16:57
06/18/21
06/18
16:57
06/18/21
16:57
BGNE

BeiGene

$321.99 /

-7.92 (-2.40%)

BeiGene, Ltd. announced…

BeiGene, Ltd. announced that BRUKINSA has received conditional approval from the China National Medical Products Administration for the treatment of adult patients with Waldenstrom's macroglobulinemia who have received at least one prior therapy. The supplemental new drug application was previously granted priority review by the Center for Drug Evaluation of the NMPA in October 2020.

ShowHide Related Items >><<
BGNE BeiGene
$321.99 /

-7.92 (-2.40%)

BGNE BeiGene
$321.99 /

-7.92 (-2.40%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BGNE BeiGene
$321.99 /

-7.92 (-2.40%)

  • 02
    Dec
Hot Stocks
CytRx notes Orphazyme regulatory update from FDA on arimoclomol » 16:44
06/18/21
06/18
16:44
06/18/21
16:44
CYTR

CytRx

$1.08 /

-1.74 (-61.70%)

, ORPH

Orphazyme

$7.31 /

-7.24 (-49.76%)

CytRx Corporation (CYTR)…

CytRx Corporation (CYTR) noted that Orphazyme A/S (ORPH) announced it has received a Complete Response Letter, or CRL, from the FDA following its review of the new drug application for arimoclomol, a heat shock protein amplifier intended for the treatment of Niemann-Pick disease type C, or NPC. CytRx's drug candidate, arimoclomol, was sold to Orphazyme in exchange for milestone payments and royalties. Orphazyme's announcement disclosed that the FDA issued the CRL based on needing additional qualitative and quantitative evidence to further substantiate the validity and interpretation of the 5-domain NPC Clinical Severity Scale and, in particular, the swallow domain. Further, the FDA noted in the CRL that additional data are needed to bolster confirmatory evidence beyond the single phase 2/3 clinical trial to support the benefit-risk assessment of the NDA. A primary endpoint of the phase 2/3 clinical trial was progression in disease severity as measured by the 5-domain NPCCSS. This is a disease-specific measure of disease progression consisting of the five clinically most relevant domains to patients with NPC, caregivers and physicians. Orphazyme CEO Christophe Bourdon stated: "We are disheartened by the outcome of the FDA's review, given the urgent need for a new therapeutic option for NPC, but we remain committed to working with the regulators, with the goal of delivering arimoclomol to families managing this challenging disease. We will focus our efforts on pursuing the European regulatory approval, with CHMP opinion expected in Q4 2021 and potential Marketing Authorization in Q1 2022. We are assessing the potential path forward in the U.S. in partnership with the FDA. In the short-term, we will need to reduce our costs substantially and freeze all company efforts not related to clinical and regulatory activities to support approval for NPC." The outcome of the FDA decision has significant influence on Orphazyme's outlook for FY21. Orphazyme's cash position at year-end 2021 is now expected to be approximately $8, where it was previously $56M.

ShowHide Related Items >><<
ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

CYTR CytRx
$1.08 /

-1.74 (-61.70%)

CYTR CytRx
$1.08 /

-1.74 (-61.70%)

ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

06/18/21 Cowen
Orphazyme downgraded to Market Perform from Outperform at Cowen
03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
  • 29
    Sep
ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

Hot Stocks
Boeing completes successful 737-10 first flight » 16:34
06/18/21
06/18
16:34
06/18/21
16:34
BA

Boeing

$237.44 /

-1.67 (-0.70%)

Boeing's 737-10, the…

Boeing's 737-10, the largest airplane in the 737 MAX family, completed a successful first flight on June 18. The airplane took off from Renton Field in Renton, Washington, at 10:07 a.m. and landed at 12:38 p.m. at Boeing Field in Seattle. The flight was the start of a comprehensive test program for the 737-10. Boeing will work closely with regulators to certify the airplane prior to its scheduled entry into service in 2023.

ShowHide Related Items >><<
BA Boeing
$237.44 /

-1.67 (-0.70%)

BA Boeing
$237.44 /

-1.67 (-0.70%)

06/15/21 Berenberg
Boeing price target raised to $245 from $215 at Berenberg
06/10/21 Jefferies
Boeing shares could move up 5% on China recertification, says Jefferies
06/09/21 Susquehanna
Boeing estimates lowered on light May deliveries, says Susquehanna
06/03/21 Morgan Stanley
Morgan Stanley says recovery tailwinds can offset new launch headwinds at Boeing
BA Boeing
$237.44 /

-1.67 (-0.70%)

BA Boeing
$237.44 /

-1.67 (-0.70%)

BA Boeing
$237.44 /

-1.67 (-0.70%)

BA Boeing
$237.44 /

-1.67 (-0.70%)

Hot Stocks
Pyxis Tankers announces receipt of Nasdaq notice » 16:31
06/18/21
06/18
16:31
06/18/21
16:31
PXS

Pyxis Tankers

/

+

Pyxis Tankers Inc.…

Pyxis Tankers Inc. announced that on June 16, 2021, it received a notification letter from the Nasdaq Stock Market, stating that, for a period of 30 consecutive business days, the company's common shares closed below the minimum bid price of $1.00 per share, as required for continued listing on Nasdaq. The company has until December 13, 2021 to regain compliance with the Minimum Bid Price Requirement. The company can cure this deficiency if the closing bid price of its common shares is $1.00 per share or higher for at least ten consecutive business days during the Compliance Period. The company intends to regain compliance with the minimum bid price requirement within the Compliance Period and is considering all available options, including a reverse stock split. During this time, the company's common shares will continue to be listed and traded on the Nasdaq Capital Market, and this notice will have no effect on the operations of the company's business. If the company does not regain compliance during the Compliance Period, it may be eligible for an additional 180 calendar day compliance period. If the Nasdaq staff concludes that the company will not be able to cure the deficiency or if the company is otherwise not eligible, the company's common shares will be subject to delisting by Nasdaq.

ShowHide Related Items >><<
PXS Pyxis Tankers
/

+

PXS Pyxis Tankers
/

+

02/17/21 Noble Capital
Pyxis Tankers downgraded to Market Perform from Outperform at Noble Capital
PXS Pyxis Tankers
/

+

Options
Preliminary option volume of 48.9M today » 16:30
06/18/21
06/18
16:30
06/18/21
16:30

Preliminary option volume…

Preliminary option volume of 48.9M today is 31% above recent average. Calls led puts 28.73M to 20.13M.

General news
Treasury Market Summary » 16:30
06/18/21
06/18
16:30
06/18/21
16:30
$ECON

Economic Data

/

+

Treasury Market Summary:…

Treasury Market Summary: the markets continued to react to the FOMC's hawkish shift, with comments from St Louis Fed's Bullard the latest catalyst for the day's roiling. He noted in an interview that he filled in a dot for a late 2022 rate hike given his estimate for a 3% rate of core PCE inflation this year and 2.5% for 2022. That added to worries the FOMC could begin its QE taper later this year and begin hiking rates sooner than previously expected. The combination of rising rates and reduced QE as the Fed addresses inflation pressures were the recipe for a hefty bear flattening trade with the front end underperforming. Wall Street was hammered and had one of its worst sessions in some time. Losses were broadbased with the broader indexes underperforming as reflation trades were liquidated. The Dow dropped -1.58% with the S&P 500 down -1.3%, and the NASDAQ off -0.92%.

ShowHide Related Items >><<
$ECON Economic Data
/

+

Conference/Events
Ingevity to hold a virtual investor meeting » 16:28
06/18/21
06/18
16:28
06/18/21
16:28
NGVT

Ingevity

$79.70 /

+0.145 (+0.18%)

Virtual Investor Meeting…

Virtual Investor Meeting to discuss innovative new pathways for activated carbon will be held on June 30 at 10 am. Webcast Link

ShowHide Related Items >><<
NGVT Ingevity
$79.70 /

+0.145 (+0.18%)

NGVT Ingevity
$79.70 /

+0.145 (+0.18%)

05/27/21 Loop Capital
Ingevity price target raised to $85 from $71 at Loop Capital
05/04/21 BMO Capital
Ingevity price target raised to $110 from $100 at BMO Capital
02/11/21 Oppenheimer
Ingevity price target raised to $85 from $75 at Oppenheimer
02/08/21 Loop Capital
Ingevity downgraded to Hold from Buy at Loop Capital
NGVT Ingevity
$79.70 /

+0.145 (+0.18%)

Periodicals
YouTube tells MacRumors iOS app to soon include picture-in-picture support » 16:21
06/18/21
06/18
16:21
06/18/21
16:21
GOOG

Alphabet

$2,510.66 /

-19.215 (-0.76%)

, GOOGL

Alphabet Class A

$2,401.50 /

-32.255 (-1.33%)

, AAPL

Apple

$130.40 /

-1.39 (-1.05%)

YouTube's (GOOG) iOS…

YouTube's (GOOG) iOS and iPadOS (AAPL) apps will soon include picture-in-picture support, allowing all users to close the YouTube app and continuing watching a video in a smaller window, MacRumors' Sami Fathi reports. YouTube told MacRumos that the feature is currently rolling out to all premium iOS subscribers and that a wider launch to all U.S. iOS users will occur soon. Reference Link

ShowHide Related Items >><<
GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

AAPL Apple
$130.40 /

-1.39 (-1.05%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

06/16/21 Jefferies
Jefferies adds Amazon.com to Franchise Picks list, removes Alphabet
06/11/21 Tigress Financial
Tigress sees Alphabet shares rising to $3,185 in 12 months
06/02/21 KGI Securities
Alphabet initiated with an Outperform at KGI Securities
05/19/21 JPMorgan
Broadcom continues to win AI chip work at Google, says JPMorgan
GOOGL Alphabet Class A
$2,401.50 /

-32.255 (-1.33%)

06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
AAPL Apple
$130.40 /

-1.39 (-1.05%)

06/17/21 Loop Capital
Loop Capital starts Cirrus Logic at Buy, cites content gains at Apple
06/11/21 Argus
Apple underperformance due to sector rotation, not misfires, says Argus
06/08/21 RBC Capital
Fisker initiated with an Outperform at RBC Capital
06/08/21 BofA
Apple App store growth decelerating in Q3 to-date, says BofA
GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

AAPL Apple
$130.40 /

-1.39 (-1.05%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

AAPL Apple
$130.40 /

-1.39 (-1.05%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

AAPL Apple
$130.40 /

-1.39 (-1.05%)

GOOGL Alphabet Class A
$2,401.50 /

-32.255 (-1.33%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

AAPL Apple
$130.40 /

-1.39 (-1.05%)

Options
Closing CBOE SPX and VIX Index summary for June 18th » 16:20
06/18/21
06/18
16:20
06/18/21
16:20
VIX

Volatility Index S&P 500 Options

/

+

The CBOE Volatility Index…

The CBOE Volatility Index (VIX), the SPX option derived measure of implied volatility, lifted 2.95 today to close at 20.70, while the underlying SPX index lost 55.41 to close at $4166.45, a 1.31% decline. 468,689 VIX option contracts traded, 87.51% of the typical daily volume for the product. Calls made up 53.8% of the volume.

ShowHide Related Items >><<
VIX Volatility Index S&P 500 Options
/

+

Technical Analysis
NASDAQ market internals summary » 16:17
06/18/21
06/18
16:17
06/18/21
16:17
$NSD

NASDAQ Market Internals

/

+

Volume was above average…

Volume was above average for this time of day. Breadth was mixed with issues and volume bearish while new highs to new lows were bullish (positive divergence). Advancing Issues: 1276 / Declining Issues: 3032 -- for a ratio of 0.4 to 1. Advancing Volume: 2,005,999,000 / Declining Volume: 3,778,342,000 -- for a ratio of 0.5 to 1. New 52-Week Highs: 93 / New 52-Week Lows: 64.

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 16:16
06/18/21
06/18
16:16
06/18/21
16:16
$NYE

NYSE Market Internals

/

+

Volume was above average…

Volume was above average for this time of day. Breadth was mixed with issues and volume bearish while new highs to new lows were bullish (positive divergence). Advancing Issues: 839 / Declining Issues: 2496 -- for a ratio of 0.3 to 1. Advancing Volume: 857,039,000 / Declining Volume: 5,223,108,000 -- for a ratio of 0.2 to 1. New 52-Week Highs: 86 / New 52-Week Lows: 33.

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:15
06/18/21
06/18
16:15
06/18/21
16:15
CAI

CAI International

$56.03 /

+17.84 (+46.71%)

, ORPH

Orphazyme

$7.31 /

-7.24 (-49.76%)

, PYPL

PayPal

$283.42 /

+5.345 (+1.92%)

, FOX

Fox Corp.

$35.81 /

+0.35 (+0.99%)

, FOXA

Fox Corp.

$37.62 /

+0.46 (+1.24%)

, SYKE

Sykes Enterprises

$53.54 /

+12.31 (+29.86%)

, BIIB

Biogen

$388.19 /

+4.97 (+1.30%)

, CURI

CuriosityStream

$12.66 /

-2.125 (-14.38%)

, DAL

Delta Air Lines

$44.97 /

+0.39 (+0.87%)

, ALK

Alaska Air

$63.26 /

+0.6 (+0.96%)

, UAL

United Airlines

$54.90 /

+0.66 (+1.22%)

, NVDA

Nvidia

$743.88 /

-2.64 (-0.35%)

, MU

Micron

$76.95 /

-3.69 (-4.58%)

, EBAY

eBay

$63.25 /

-2.07 (-3.17%)

, MAT

Mattel

$19.40 /

+0.08 (+0.41%)

, HAS

Hasbro

$91.05 /

-0.72 (-0.78%)

, RDS.A

Royal Dutch Shell

$39.09 /

-2.16 (-5.24%)

, RDS.B

Royal Dutch Shell

$37.22 /

-2.05 (-5.22%)

, NYT

New York Times

$40.92 /

+0.6 (+1.49%)

, GOOG

Alphabet

$2,510.66 /

-19.215 (-0.76%)

, GOOGL

Alphabet Class A

$2,401.50 /

-32.255 (-1.33%)

, GERN

Geron

$1.82 /

+0.425 (+30.47%)

, GEO

Geo Group

$7.62 /

+0.395 (+5.47%)

, DOCU

DocuSign

$274.38 /

+13.58 (+5.21%)

, ACRE

Ares Commercial

$14.50 /

-1.8 (-11.04%)

, ADBE

Adobe

$565.64 /

+14.69 (+2.67%)

, SWBI

Smith & Wesson Brands

$23.38 /

+3.45 (+17.31%)

, CDXS

Codexis

$22.06 /

+2.41 (+12.26%)

, X

U.S. Steel

$22.69 /

-1.1 (-4.62%)

, DLNG

Dynagas LNG

$2.81 /

-0.32 (-10.22%)

, ATHA

Athira Pharma

$11.06 /

-7.17 (-39.33%)

Get caught up quickly on…

ShowHide Related Items >><<
X U.S. Steel
$22.69 /

-1.1 (-4.62%)

UAL United Airlines
$54.90 /

+0.66 (+1.22%)

SYKE Sykes Enterprises
$53.54 /

+12.31 (+29.86%)

SWBI Smith & Wesson Brands
$23.38 /

+3.45 (+17.31%)

RDS.B Royal Dutch Shell
$37.22 /

-2.05 (-5.22%)

RDS.A Royal Dutch Shell
$39.09 /

-2.16 (-5.24%)

PYPL PayPal
$283.42 /

+5.345 (+1.92%)

ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

NYT New York Times
$40.92 /

+0.6 (+1.49%)

NVDA Nvidia
$743.88 /

-2.64 (-0.35%)

MU Micron
$76.95 /

-3.69 (-4.58%)

MAT Mattel
$19.40 /

+0.08 (+0.41%)

HAS Hasbro
$91.05 /

-0.72 (-0.78%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

GERN Geron
$1.82 /

+0.425 (+30.47%)

GEO Geo Group
$7.62 /

+0.395 (+5.47%)

FOX Fox Corp.
$35.81 /

+0.35 (+0.99%)

EBAY eBay
$63.25 /

-2.07 (-3.17%)

DOCU DocuSign
$274.38 /

+13.58 (+5.21%)

DLNG Dynagas LNG
$2.81 /

-0.32 (-10.22%)

DAL Delta Air Lines
$44.97 /

+0.39 (+0.87%)

CURI CuriosityStream
$12.66 /

-2.125 (-14.38%)

CDXS Codexis
$22.06 /

+2.41 (+12.26%)

CAI CAI International
$56.03 /

+17.84 (+46.71%)

BIIB Biogen
$388.19 /

+4.97 (+1.30%)

ATHA Athira Pharma
$11.06 /

-7.17 (-39.33%)

ALK Alaska Air
$63.26 /

+0.6 (+0.96%)

ADBE Adobe
$565.64 /

+14.69 (+2.67%)

ACRE Ares Commercial
$14.50 /

-1.8 (-11.04%)

CAI CAI International
$56.03 /

+17.84 (+46.71%)

06/18/21 B. Riley
CAI International downgraded to Neutral from Buy at B. Riley
06/09/21 B. Riley
CAI International transferred with Buy at B. Riley
03/26/21 B. Riley
CAI International price target raised to $60 from $50 at B. Riley Securities
02/17/21 B. Riley
CAI International price target raised to $50 from $44 at B. Riley Securities
ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

06/18/21 Cowen
Orphazyme downgraded to Market Perform from Outperform at Cowen
03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
PYPL PayPal
$283.42 /

+5.345 (+1.92%)

05/07/21 BMO Capital
PayPal price target raised to $256 from $241 at BMO Capital
05/07/21 Oppenheimer
PayPal price target raised to $322 from $310 at Oppenheimer
05/06/21 Oppenheimer
PayPal price target raised to $322 from $310 at Oppenheimer
05/06/21 Credit Suisse
PayPal price target raised to $315 from $310 at Credit Suisse
FOX Fox Corp.
$35.81 /

+0.35 (+0.99%)

05/06/21 RBC Capital
Fox Corp. price target raised to $42 from $36 at RBC Capital
05/06/21 UBS
Fox Corp price target raised to $39 from $30 at UBS
04/27/21 Morgan Stanley
Fox Corp. price target raised to $45 from $36 at Morgan Stanley
10/30/20 Morgan Stanley
Morgan Stanley says ad recovery lifts outlook for Fox Corp.
FOXA Fox Corp.
$37.62 /

+0.46 (+1.24%)

06/09/21 Wells Fargo
Fox upgraded to Overweight on sports betting opportunity at Wells Fargo
06/09/21 Wells Fargo
Fox Corp. upgraded to Overweight from Equal Weight at Wells Fargo
05/18/21 Morgan Stanley
Morgan Stanley says Amazon-MGM would be 'biggest signal yet' of streaming focus
05/18/21 Evercore ISI
Evercore says market likely views Discovery deal negatively for ViacomCBS, Fox
SYKE Sykes Enterprises
$53.54 /

+12.31 (+29.86%)

06/18/21 Sidoti
Sykes Enterprises downgraded to Neutral from Buy at Sidoti
05/06/21 Barrington
Sykes Enterprises price target raised to $50 from $48 at Barrington
02/25/21 Barrington
Sykes Enterprises price target raised to $48 from $46 at Barrington
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
BIIB Biogen
$388.19 /

+4.97 (+1.30%)

06/18/21
Fly Intel: Top five analyst upgrades
06/18/21 Jefferies
Jefferies a buyer of Prothena on Biogen's negative Tau disappointment pullback
06/18/21 BofA
BofA upgrades Prothena to Neutral on PRX012 potential following Aduhelm approval
06/18/21 Piper Sandler
Biogen upgraded to Overweight from Neutral at Piper Sandler
CURI CuriosityStream
$12.66 /

-2.125 (-14.38%)

06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 BofA
CuriosityStream double-downgraded to Underperform at BofA on valuation
06/18/21 BofA
CuriosityStream downgraded to Underperform from Buy at BofA
05/13/21 Barrington
CuriosityStream price target lowered to $14 from $21 at Barrington
DAL Delta Air Lines
$44.97 /

+0.39 (+0.87%)

06/18/21 Wolfe Research
Wolfe Research upgrades three airlines on 'pent-up demand scenario'
06/18/21 Wolfe Research
Delta Air Lines upgraded to Outperform from Underperform at Wolfe Research
06/09/21 MKM Partners
MKM Partners starts Delta Air Lines at Buy, calls stock Top Pick
06/09/21 MKM Partners
Delta Air Lines initiated with a Buy at MKM Partners
ALK Alaska Air
$63.26 /

+0.6 (+0.96%)

06/18/21 Wolfe Research
Alaska Air upgraded to Outperform from Peer Perform at Wolfe Research
06/09/21 MKM Partners
Alaska Air initiated with a Buy at MKM Partners
06/09/21 MKM Partners
Alaska Air initiated with a Buy at MKM Partners
UAL United Airlines
$54.90 /

+0.66 (+1.22%)

06/18/21 Wolfe Research
United Airlines upgraded to Peer Perform from Underperform at Wolfe Research
06/09/21 MKM Partners
United Airlines initiated with a Neutral at MKM Partners
04/21/21 Deutsche Bank
United Airlines named 'Catalyst Call: Buy' at Deutsche Bank
NVDA Nvidia
$743.88 /

-2.64 (-0.35%)

06/18/21 Jefferies
Intel price target lowered to $54 from $59 at Jefferies
06/18/21 BofA
BofA ups Nvidia target to $900, sees data center sales tripling by 2025
06/17/21 Jefferies
Nvidia price target raised to $854 from $740 at Jefferies
06/08/21 Rosenblatt
Marvell price target raised to $70 from $60 at Rosenblatt
MU Micron
$76.95 /

-3.69 (-4.58%)

06/18/21 Lynx
Micron should not be bought on today's selloff, says Lynx
06/18/21 Cleveland Research
Micron downgraded to Neutral from Buy at Cleveland Research
06/17/21
Fly Intel: Top five analyst downgrades
06/17/21 Lynx
Micron downgraded to Sell from Hold at Lynx
EBAY eBay
$63.25 /

-2.07 (-3.17%)

06/16/21 Baird
eBay volume appears to be tracking in-line, says Baird
05/03/21 BMO Capital
eBay price target lowered to $63 from $67 at BMO Capital
04/29/21
Fly Intel: Top five analyst downgrades
04/29/21 Wedbush
eBay downgraded to Neutral at Wedbush on lower visibility into post-COVID GMV
MAT Mattel
$19.40 /

+0.08 (+0.41%)

06/17/21 JPMorgan
Mattel's 'fast entry' into NFT testament to evolution, says JPMorgan
04/26/21 BMO Capital
Mattel price target raised to $30 from $26 at BMO Capital
04/23/21 MKM Partners
Mattel price target raised to $23 from $21 at MKM Partners
04/21/21 Berenberg
Mattel upgraded to Buy from Hold at Berenberg
HAS Hasbro
$91.05 /

-0.72 (-0.78%)

04/29/21 KeyBanc
Hasbro price target raised to $105 from $100 at KeyBanc
04/13/21 Stifel
Mattel price target raised to $22 from $19.50 at Stifel
03/29/21 MKM Partners
Hasbro reached 'important milestones' in videogame business, says MKM Partners
RDS.A Royal Dutch Shell
$39.09 /

-2.16 (-5.24%)

06/08/21 DZ Bank
Royal Dutch Shell downgraded to Hold from Buy at DZ Bank
05/17/21 Mizuho
Royal Dutch Shell price target raised to $61 from $56 at Mizuho
04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
RDS.B Royal Dutch Shell
$37.22 /

-2.05 (-5.22%)

04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
NYT New York Times
$40.92 /

+0.6 (+1.49%)

05/06/21 JPMorgan
New York Times shares may be range-bound near term, says JPMorgan
03/18/21 Guggenheim
Guggenheim upgrades News Corp. to Buy, sees 'significant value' to be unlocked
11/09/20 Evercore ISI
New York Times upgraded to Outperform from In Line at Evercore ISI
10/27/20 JPMorgan
New York Times selloff brings attractive entry point, says JPMorgan
GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

06/16/21 Jefferies
Jefferies adds Amazon.com to Franchise Picks list, removes Alphabet
06/11/21 Tigress Financial
Tigress sees Alphabet shares rising to $3,185 in 12 months
06/02/21 KGI Securities
Alphabet initiated with an Outperform at KGI Securities
05/19/21 JPMorgan
Broadcom continues to win AI chip work at Google, says JPMorgan
GOOGL Alphabet Class A
$2,401.50 /

-32.255 (-1.33%)

06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
GERN Geron
$1.82 /

+0.425 (+30.47%)

02/18/21 B. Riley
Geron transferred with Buy rating at B. Riley Securities
10/14/20 B. Riley
Geron shares have 100% potential upside, says B. Riley Securities
08/26/20 H.C. Wainwright
Geron price target raised to $7 from $4 at H.C. Wainwright
08/03/20
Fly Intel: Top five analyst initiations
GEO Geo Group
$7.62 /

+0.395 (+5.47%)

06/08/21 Wedbush
Wedbush sees Geo Group facing two major headwinds, initiates with Neutral
06/08/21 Wedbush
Geo Group initiated with a Neutral at Wedbush
06/29/20 Noble Capital
Geo Group initiated with an Outperform at Noble Capital
DOCU DocuSign
$274.38 /

+13.58 (+5.21%)

06/18/21 Wedbush
DocuSign price target raised to $290 from $260 at Wedbush
06/10/21 RBC Capital
DocuSign assumed with an Outperform at RBC Capital
06/04/21 Wedbush
DocuSign price target lowered to $260 from $300 at Wedbush
06/04/21 Morgan Stanley
DocuSign price target raised to $295 from $290 at Morgan Stanley
ACRE Ares Commercial
$14.50 /

-1.8 (-11.04%)

04/26/21 JPMorgan
Ares Commercial price target raised to $13.50 from $12.50 at JPMorgan
02/02/21 BTIG
Ares Commercial initiated with a Buy at BTIG
11/20/20 Raymond James
Ares Commercial downgraded to Outperform from Strong Buy at Raymond James
11/20/20 Raymond James
Ares Commercial downgraded to Outperform from Strong Buy at Raymond James
ADBE Adobe
$565.64 /

+14.69 (+2.67%)

06/18/21 JPMorgan
Adobe price target raised to $660 from $595 at JPMorgan
06/18/21 Evercore ISI
Adobe price target raised to $625 from $550 at Evercore ISI
06/18/21 BMO Capital
Adobe price target raised to $630 from $585 at BMO Capital
06/18/21 Goldman Sachs
Adobe price target raised to $665 from $580 at Goldman Sachs
SWBI Smith & Wesson Brands
$23.38 /

+3.45 (+17.31%)

03/05/21
Fly Intel: Top five analyst downgrades
03/05/21 Lake Street
Smith & Wesson Brands price target raised to $34 from $28 at Lake Street
03/05/21 Craig-Hallum
Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum
03/05/21 Craig-Hallum
Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum
CDXS Codexis
$22.06 /

+2.41 (+12.26%)

04/12/21 Piper Sandler
Codexis initiated with an Overweight at Piper Sandler
03/01/21 Stifel
Codexis initiated with a Buy at Stifel
12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
X U.S. Steel
$22.69 /

-1.1 (-4.62%)

06/16/21
Fly Intel: Top five analyst downgrades
06/16/21 JPMorgan
U.S. Steel assumed with Underweight from Neutral at JPMorgan
06/10/21 GLJ Research
GLJ ups U.S. Steel target, says valuation 'materially below reality'
06/04/21
Fly Intel: Top five analyst upgrades
DLNG Dynagas LNG
$2.81 /

-0.32 (-10.22%)

06/18/21 Stifel
Stifel upgrades Dynagas LNG to Buy as leverage comes down
06/18/21 Stifel
Dynagas LNG upgraded to Buy from Hold at Stifel
01/29/21 Jefferies
Dynagas LNG price target raised to $3 from $2.50 at Jefferies
ATHA Athira Pharma
$11.06 /

-7.17 (-39.33%)

06/18/21 Jefferies
Athira Pharma's 'unusual situation' to cause some volatility, says Jefferies
06/18/21 Stifel
Athira Pharma CEO leave situation 'impossible to really vet,' says Stifel
06/07/21 JMP Securities
Aducanumab accelerated approval positive for Athira, others, says JMP Securities
06/07/21 Goldman Sachs
Goldman says Biogen approval has positive read to Alector, Athira
X U.S. Steel
$22.69 /

-1.1 (-4.62%)

UAL United Airlines
$54.90 /

+0.66 (+1.22%)

SYKE Sykes Enterprises
$53.54 /

+12.31 (+29.86%)

SWBI Smith & Wesson Brands
$23.38 /

+3.45 (+17.31%)

RDS.A Royal Dutch Shell
$39.09 /

-2.16 (-5.24%)

PYPL PayPal
$283.42 /

+5.345 (+1.92%)

NYT New York Times
$40.92 /

+0.6 (+1.49%)

NVDA Nvidia
$743.88 /

-2.64 (-0.35%)

MU Micron
$76.95 /

-3.69 (-4.58%)

MAT Mattel
$19.40 /

+0.08 (+0.41%)

HAS Hasbro
$91.05 /

-0.72 (-0.78%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

GERN Geron
$1.82 /

+0.425 (+30.47%)

GEO Geo Group
$7.62 /

+0.395 (+5.47%)

FOXA Fox Corp.
$37.62 /

+0.46 (+1.24%)

FOX Fox Corp.
$35.81 /

+0.35 (+0.99%)

EBAY eBay
$63.25 /

-2.07 (-3.17%)

DOCU DocuSign
$274.38 /

+13.58 (+5.21%)

DLNG Dynagas LNG
$2.81 /

-0.32 (-10.22%)

DAL Delta Air Lines
$44.97 /

+0.39 (+0.87%)

CURI CuriosityStream
$12.66 /

-2.125 (-14.38%)

CDXS Codexis
$22.06 /

+2.41 (+12.26%)

CAI CAI International
$56.03 /

+17.84 (+46.71%)

BIIB Biogen
$388.19 /

+4.97 (+1.30%)

ATHA Athira Pharma
$11.06 /

-7.17 (-39.33%)

ALK Alaska Air
$63.26 /

+0.6 (+0.96%)

ADBE Adobe
$565.64 /

+14.69 (+2.67%)

ACRE Ares Commercial
$14.50 /

-1.8 (-11.04%)

  • 18
    Jun
  • 16
    Mar
  • 03
    Feb
  • 04
    Feb
  • 21
    Jan
  • 03
    Dec
  • 29
    Sep
  • 18
    Sep
X U.S. Steel
$22.69 /

-1.1 (-4.62%)

UAL United Airlines
$54.90 /

+0.66 (+1.22%)

SWBI Smith & Wesson Brands
$23.38 /

+3.45 (+17.31%)

RDS.B Royal Dutch Shell
$37.22 /

-2.05 (-5.22%)

RDS.A Royal Dutch Shell
$39.09 /

-2.16 (-5.24%)

PYPL PayPal
$283.42 /

+5.345 (+1.92%)

NYT New York Times
$40.92 /

+0.6 (+1.49%)

NVDA Nvidia
$743.88 /

-2.64 (-0.35%)

MU Micron
$76.95 /

-3.69 (-4.58%)

MAT Mattel
$19.40 /

+0.08 (+0.41%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

GEO Geo Group
$7.62 /

+0.395 (+5.47%)

FOXA Fox Corp.
$37.62 /

+0.46 (+1.24%)

FOX Fox Corp.
$35.81 /

+0.35 (+0.99%)

EBAY eBay
$63.25 /

-2.07 (-3.17%)

DOCU DocuSign
$274.38 /

+13.58 (+5.21%)

DAL Delta Air Lines
$44.97 /

+0.39 (+0.87%)

BIIB Biogen
$388.19 /

+4.97 (+1.30%)

ALK Alaska Air
$63.26 /

+0.6 (+0.96%)

X U.S. Steel
$22.69 /

-1.1 (-4.62%)

UAL United Airlines
$54.90 /

+0.66 (+1.22%)

SWBI Smith & Wesson Brands
$23.38 /

+3.45 (+17.31%)

RDS.A Royal Dutch Shell
$39.09 /

-2.16 (-5.24%)

PYPL PayPal
$283.42 /

+5.345 (+1.92%)

ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

NYT New York Times
$40.92 /

+0.6 (+1.49%)

NVDA Nvidia
$743.88 /

-2.64 (-0.35%)

MU Micron
$76.95 /

-3.69 (-4.58%)

MAT Mattel
$19.40 /

+0.08 (+0.41%)

HAS Hasbro
$91.05 /

-0.72 (-0.78%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

FOXA Fox Corp.
$37.62 /

+0.46 (+1.24%)

FOX Fox Corp.
$35.81 /

+0.35 (+0.99%)

EBAY eBay
$63.25 /

-2.07 (-3.17%)

DOCU DocuSign
$274.38 /

+13.58 (+5.21%)

DAL Delta Air Lines
$44.97 /

+0.39 (+0.87%)

CURI CuriosityStream
$12.66 /

-2.125 (-14.38%)

CAI CAI International
$56.03 /

+17.84 (+46.71%)

BIIB Biogen
$388.19 /

+4.97 (+1.30%)

ATHA Athira Pharma
$11.06 /

-7.17 (-39.33%)

ALK Alaska Air
$63.26 /

+0.6 (+0.96%)

ADBE Adobe
$565.64 /

+14.69 (+2.67%)

X U.S. Steel
$22.69 /

-1.1 (-4.62%)

UAL United Airlines
$54.90 /

+0.66 (+1.22%)

SWBI Smith & Wesson Brands
$23.38 /

+3.45 (+17.31%)

PYPL PayPal
$283.42 /

+5.345 (+1.92%)

ORPH Orphazyme
$7.31 /

-7.24 (-49.76%)

NVDA Nvidia
$743.88 /

-2.64 (-0.35%)

MU Micron
$76.95 /

-3.69 (-4.58%)

GOOGL Alphabet Class A
$2,401.50 /

-32.255 (-1.33%)

GOOG Alphabet
$2,510.66 /

-19.215 (-0.76%)

GEO Geo Group
$7.62 /

+0.395 (+5.47%)

FOXA Fox Corp.
$37.62 /

+0.46 (+1.24%)

FOX Fox Corp.
$35.81 /

+0.35 (+0.99%)

EBAY eBay
$63.25 /

-2.07 (-3.17%)

DOCU DocuSign
$274.38 /

+13.58 (+5.21%)

DAL Delta Air Lines
$44.97 /

+0.39 (+0.87%)

CURI CuriosityStream
$12.66 /

-2.125 (-14.38%)

BIIB Biogen
$388.19 /

+4.97 (+1.30%)

ATHA Athira Pharma
$11.06 /

-7.17 (-39.33%)

ADBE Adobe
$565.64 /

+14.69 (+2.67%)

Conference/Events
Cemex to hold a company meeting » 16:11
06/18/21
06/18
16:11
06/18/21
16:11
CX

Cemex

$7.49 /

-0.125 (-1.64%)

Virtual CEMEX Day 2021 to…

Virtual CEMEX Day 2021 to be held on June 24 at 10 am. Webcast Link

ShowHide Related Items >><<
CX Cemex
$7.49 /

-0.125 (-1.64%)

CX Cemex
$7.49 /

-0.125 (-1.64%)

06/15/21 Berenberg
Cemex assumed with a Buy at Berenberg
05/10/21 Jefferies
Eagle Materials upgraded to Buy at Jefferies on cement and wallboard pricing
04/30/21 Barclays
Cemex price target raised to $10 from $8 at Barclays
04/23/21 Exane BNP Paribas
Cemex upgraded to Outperform from Neutral at Exane BNP Paribas
CX Cemex
$7.49 /

-0.125 (-1.64%)

CX Cemex
$7.49 /

-0.125 (-1.64%)

On The Fly
Bet On It: Ohio lawmakers pass sports betting bill 30-2 » 16:09
06/18/21
06/18
16:09
06/18/21
16:09
DKNG

DraftKings

$48.05 /

-1.17 (-2.38%)

, AUD

Audacy

$4.09 /

-0.14 (-3.31%)

, MGM

MGM Resorts

$40.98 /

-0.39 (-0.94%)

, CHDN

Churchill Downs

$191.40 /

-0.49 (-0.26%)

, BALY

Bally's

$50.94 /

+0.05 (+0.10%)

, PENN

Penn National

$74.00 /

-2.13 (-2.80%)

, GNOG

Golden Nugget Online

$12.69 /

-0.195 (-1.51%)

, CZR

Caesars

$100.03 /

-3.73 (-3.59%)

, WYNN

Wynn Resorts

$124.74 /

-0.57 (-0.45%)

, ACEL

Accel Entertainment

$11.86 /

-0.39 (-3.18%)

, BYD

Boyd Gaming

$58.89 /

-0.93 (-1.55%)

, GAN

Gan Limited

$17.82 /

-0.21 (-1.16%)

, GENI

Genius Sports

$18.05 /

-0.655 (-3.50%)

, LVS

Las Vegas Sands

$53.14 /

-0.99 (-1.83%)

, RSI

Rush Street Interactive

$12.55 /

-0.72 (-5.43%)

, SGMS

Scientific Games

$72.18 /

-3.43 (-4.54%)

, SCR

Score Media

$22.61 /

-1.61 (-6.65%)

Welcome to the latest…

ShowHide Related Items >><<
WYNN Wynn Resorts
$124.74 /

-0.57 (-0.45%)

SGMS Scientific Games
$72.18 /

-3.43 (-4.54%)

RSI Rush Street Interactive
$12.55 /

-0.72 (-5.43%)

PENN Penn National
$74.00 /

-2.13 (-2.80%)

MGM MGM Resorts
$40.98 /

-0.39 (-0.94%)

GNOG Golden Nugget Online
$12.69 /

-0.195 (-1.51%)

GENI Genius Sports
$18.05 /

-0.655 (-3.50%)

GAN Gan Limited
$17.82 /

-0.21 (-1.16%)

DKNG DraftKings
$48.05 /

-1.17 (-2.38%)

CZR Caesars
$100.03 /

-3.73 (-3.59%)

CHDN Churchill Downs
$191.40 /

-0.49 (-0.26%)

BYD Boyd Gaming
$58.89 /

-0.93 (-1.55%)

BALY Bally's
$50.94 /

+0.05 (+0.10%)

AUD Audacy
$4.09 /

-0.14 (-3.31%)

ACEL Accel Entertainment
$11.86 /

-0.39 (-3.18%)

DKNG DraftKings
$48.05 /

-1.17 (-2.38%)

06/16/21 Jefferies
Matters in DraftKings short report remain unresolved, says Jefferies
06/16/21 Truist
Truist says SBTech and black market exposure are 'wider risk' to DraftKings
06/16/21 Susquehanna
DraftKings report referenced allegations prior to acquisition, says Susquehanna
06/16/21 Morgan Stanley
Morgan Stanley says DraftKings opportunity around core U.S. business, not SBTech
AUD Audacy
$4.09 /

-0.14 (-3.31%)

05/10/21 B. Riley
Audacy price target raised to $5.50 from $5 at B. Riley
04/20/21 B. Riley
Audacy resumed with a Neutral at B. Riley
MGM MGM Resorts
$40.98 /

-0.39 (-0.94%)

06/10/21 JPMorgan
MGM Resorts price target raised to $52 from $47 at JPMorgan
05/18/21
Fly Intel: Top five analyst upgrades
05/18/21 JPMorgan
JPMorgan upgrades MGM after 11% selloff brings 'opportunity to buy'
05/18/21 JPMorgan
MGM Resorts upgraded to Overweight from Neutral at JPMorgan
CHDN Churchill Downs
$191.40 /

-0.49 (-0.26%)

06/18/21
Fly Intel: Top five analyst initiations
06/18/21 Macquarie
Macquarie starts Churchill Downs at Outperform on racing machine growth
06/17/21 Macquarie
Churchill Downs initiated with an Outperform at Macquarie
05/14/21
Fly Intel: Top five analyst upgrades
BALY Bally's
$50.94 /

+0.05 (+0.10%)

04/27/21 Truist
Red Rock Resorts price target raised to $42 from $34 at Truist
04/27/21 Truist
MGM Resorts price target raised to $43 from $38 at Truist
04/27/21 Truist
Monarch Casino price target raised to $77 from $70 at Truist
04/27/21 Truist
Caesars price target raised to $120 from $100 at Truist
PENN Penn National
$74.00 /

-2.13 (-2.80%)

05/07/21 Morgan Stanley
Penn National selloff 'feels overdone' after 'strong' Q1, says Morgan Stanley
05/06/21 Stifel
Stifel wouldn't expect Penn National Q1 beat to drive shares 'materially higher'
04/26/21 Needham
Penn National initiated with a Buy at Needham
04/21/21 Goldman Sachs
Penn National price target raised to $158 from $153 at Goldman Sachs
GNOG Golden Nugget Online
$12.69 /

-0.195 (-1.51%)

05/18/21 Benchmark
Golden Nugget Online price target lowered to $20 from $24 at Benchmark
04/06/21
Fly Intel: Top five analyst initiations
04/06/21 Jefferies
Golden Nugget Online initiated with a Buy at Jefferies
03/24/21 Benchmark
Golden Nugget Online price target lowered to $24 from $27 at Benchmark
CZR Caesars
$100.03 /

-3.73 (-3.59%)

06/10/21 JPMorgan
Caesars price target raised to $129 from $120 at JPMorgan
06/07/21 Deutsche Bank
Caesars price target raised to $132 from $126 at Deutsche Bank
05/06/21 KeyBanc
Caesars price target raised to $125 from $110 at KeyBanc
05/05/21 Deutsche Bank
Caesars price target raised to $126 from $120 at Deutsche Bank
WYNN Wynn Resorts
$124.74 /

-0.57 (-0.45%)

05/11/21 Morgan Stanley
Wynn Resorts price target raised to $145 from $140 at Morgan Stanley
05/11/21 Citi
Citi upgrades Wynn Resorts to Neutral on 'value-enhancing' deal
05/11/21 Citi
Wynn Resorts upgraded to Neutral from Sell at Citi
04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
ACEL Accel Entertainment
$11.86 /

-0.39 (-3.18%)

06/03/21 Macquarie
Accel Entertainment price target raised to $14 from $13 at Macquarie
05/12/21 Northland
Accel Entertainment price target raised to $20 from $15 at Northland
05/12/21 Deutsche Bank
Accel Entertainment price target raised to $14 from $13 at Deutsche Bank
04/08/21 JPMorgan
Accel Entertainment initiated with an Overweight at JPMorgan
BYD Boyd Gaming
$58.89 /

-0.93 (-1.55%)

04/28/21 Deutsche Bank
Boyd Gaming price target raised to $77 from $71 at Deutsche Bank
04/27/21 Truist
Boyd Gaming price target raised to $78 from $65 at Truist
04/16/21 Deutsche Bank
Boyd Gaming price target raised to $71 from $67 at Deutsche Bank
04/08/21 KeyBanc
Boyd Gaming price target raised to $69 from $61 at KeyBanc
GAN Gan Limited
$17.82 /

-0.21 (-1.16%)

05/24/21 B. Riley
Gan Limited transferred with Buy, $26 target at B. Riley
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
03/26/21
Fly Intel: Top five analyst downgrades
GENI Genius Sports
$18.05 /

-0.655 (-3.50%)

06/07/21
Fly Intel: Top five analyst initiations
06/07/21 Needham
Genius Sports initiated with a Buy at Needham
06/02/21 Goldman Sachs
Genius Sports initiated with a Buy at Goldman Sachs
05/21/21 Benchmark
Genius Sports price target raised to $33 from $30 at Benchmark
LVS Las Vegas Sands
$53.14 /

-0.99 (-1.83%)

04/22/21 Credit Suisse
Las Vegas Sands price target raised to $69 from $58 at Credit Suisse
04/20/21 JPMorgan
Las Vegas Sands should be bought ahead of sentiment turn, says JPMorgan
04/19/21 Jefferies
Las Vegas Sands price target raised to $71 from $66 at Jefferies
RSI Rush Street Interactive
$12.55 /

-0.72 (-5.43%)

05/14/21 Benchmark
Rush Street Interactive price target lowered to $25 from $34 at Benchmark
04/26/21 Needham
Rush Street Interactive initiated with a Buy at Needham
04/16/21
Fly Intel: Top five analyst initiations
04/16/21 Jefferies
Jefferies starts Rush Street Interactive at Buy with $21 price target
SGMS Scientific Games
$72.18 /

-3.43 (-4.54%)

05/11/21 Craig-Hallum
Scientific Games price target raised to $70 from $65 at Craig-Hallum
05/10/21 Union Gaming
Scientific Games price target raised to $70 from $65 at Union Gaming
03/04/21 Credit Suisse
Scientific Games price target raised to $35 from $9 at Credit Suisse
02/09/21 Craig-Hallum
Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
SCR Score Media
$22.61 /

-1.61 (-6.65%)

03/23/21 Credit Suisse
Score Media initiated with an Outperform at Credit Suisse
03/22/21 Macquarie
Score Media initiated with an Outperform at Macquarie
WYNN Wynn Resorts
$124.74 /

-0.57 (-0.45%)

SGMS Scientific Games
$72.18 /

-3.43 (-4.54%)

RSI Rush Street Interactive
$12.55 /

-0.72 (-5.43%)

PENN Penn National
$74.00 /

-2.13 (-2.80%)

MGM MGM Resorts
$40.98 /

-0.39 (-0.94%)

LVS Las Vegas Sands
$53.14 /

-0.99 (-1.83%)

GNOG Golden Nugget Online
$12.69 /

-0.195 (-1.51%)

GAN Gan Limited
$17.82 /

-0.21 (-1.16%)

DKNG DraftKings
$48.05 /

-1.17 (-2.38%)

CZR Caesars
$100.03 /

-3.73 (-3.59%)

CHDN Churchill Downs
$191.40 /

-0.49 (-0.26%)

BYD Boyd Gaming
$58.89 /

-0.93 (-1.55%)

BALY Bally's
$50.94 /

+0.05 (+0.10%)

AUD Audacy
$4.09 /

-0.14 (-3.31%)

ACEL Accel Entertainment
$11.86 /

-0.39 (-3.18%)

  • 10
    Jun
  • 16
    Apr
  • 25
    Feb
  • 09
    Feb
  • 17
    Dec
  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
  • 24
    Sep
  • 19
    Jun
WYNN Wynn Resorts
$124.74 /

-0.57 (-0.45%)

SCR Score Media
$22.61 /

-1.61 (-6.65%)

MGM MGM Resorts
$40.98 /

-0.39 (-0.94%)

DKNG DraftKings
$48.05 /

-1.17 (-2.38%)

CHDN Churchill Downs
$191.40 /

-0.49 (-0.26%)

BALY Bally's
$50.94 /

+0.05 (+0.10%)

MGM MGM Resorts
$40.98 /

-0.39 (-0.94%)

GNOG Golden Nugget Online
$12.69 /

-0.195 (-1.51%)

GENI Genius Sports
$18.05 /

-0.655 (-3.50%)

DKNG DraftKings
$48.05 /

-1.17 (-2.38%)

CHDN Churchill Downs
$191.40 /

-0.49 (-0.26%)

AUD Audacy
$4.09 /

-0.14 (-3.31%)

WYNN Wynn Resorts
$124.74 /

-0.57 (-0.45%)

SGMS Scientific Games
$72.18 /

-3.43 (-4.54%)

SCR Score Media
$22.61 /

-1.61 (-6.65%)

RSI Rush Street Interactive
$12.55 /

-0.72 (-5.43%)

PENN Penn National
$74.00 /

-2.13 (-2.80%)

MGM MGM Resorts
$40.98 /

-0.39 (-0.94%)

LVS Las Vegas Sands
$53.14 /

-0.99 (-1.83%)

GNOG Golden Nugget Online
$12.69 /

-0.195 (-1.51%)

GENI Genius Sports
$18.05 /

-0.655 (-3.50%)

GAN Gan Limited
$17.82 /

-0.21 (-1.16%)

DKNG DraftKings
$48.05 /

-1.17 (-2.38%)

CZR Caesars
$100.03 /

-3.73 (-3.59%)

AUD Audacy
$4.09 /

-0.14 (-3.31%)

Periodicals
Coca-Cola, Monster Beverage prevail in 'Hansen's' rights case, Reuters says » 16:07
06/18/21
06/18
16:07
06/18/21
16:07
KO

Coca-Cola

$54.01 /

-0.93 (-1.69%)

, MNST

Monster Beverage

$92.05 /

-0.55 (-0.59%)

A California appellate…

A California appellate court threw out a $9.5M jury verdict for heirs of juice magnate Hubert Hansen against Coca-Cola (KO) and Monster Beverage (MSNT), which had supposedly misused Hansen's publicity rights on their "Hansen's" brand of drinks, Reuters' Blake Brittain reports. Reference Link

ShowHide Related Items >><<
MNST Monster Beverage
$92.05 /

-0.55 (-0.59%)

KO Coca-Cola
$54.01 /

-0.93 (-1.69%)

KO Coca-Cola
$54.01 /

-0.93 (-1.69%)

06/17/21 Argus
Coca-Cola price target raised to $63 from $60 at Argus
06/15/21 Credit Suisse
Coca-Cola price target raised to $62 from $60 at Credit Suisse
06/04/21 Morgan Stanley
Coca-Cola price target raised to $64 from $60 at Morgan Stanley
05/14/21 Wells Fargo
Wells says Coca-Cola Energy discontinuation may 'rekindle' Monster M&A debate
MNST Monster Beverage
$92.05 /

-0.55 (-0.59%)

06/02/21 Morgan Stanley
Survey increases confidence in Monster Beverage outlook, says Morgan Stanley
05/14/21 Evercore ISI
Coke Energy discontinuation a 'small positive' for Monster, says Evercore ISI
05/07/21 Truist
Monster Beverage price target raised to $115 from $105 at Truist
MNST Monster Beverage
$92.05 /

-0.55 (-0.59%)

KO Coca-Cola
$54.01 /

-0.93 (-1.69%)

KO Coca-Cola
$54.01 /

-0.93 (-1.69%)

MNST Monster Beverage
$92.05 /

-0.55 (-0.59%)

KO Coca-Cola
$54.01 /

-0.93 (-1.69%)

MNST Monster Beverage
$92.05 /

-0.55 (-0.59%)

KO Coca-Cola
$54.01 /

-0.93 (-1.69%)

Downgrade
Orphazyme downgraded to Market Perform from Outperform at Cowen » 15:57
06/18/21
06/18
15:57
06/18/21
15:57
ORPH

Orphazyme

$7.12 /

-7.43 (-51.07%)

Cowen analyst Ritu Baral…

Cowen analyst Ritu Baral downgraded Orphazyme to Market Perform from Outperform after the company announced it has received a complete response letter, or CRL, from the FDA following its review of the new drug application for arimoclomol.

ShowHide Related Items >><<
ORPH Orphazyme
$7.12 /

-7.43 (-51.07%)

ORPH Orphazyme
$7.12 /

-7.43 (-51.07%)

03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
03/30/21 BofA
Orphazyme downgraded to Underperform from Neutral at BofA
10/26/20 Guggenheim
Orphazyme initiated with a Buy at Guggenheim
10/26/20 BofA
Orphazyme initiated with a Buy at BofA
  • 29
    Sep
ORPH Orphazyme
$7.12 /

-7.43 (-51.07%)

ORPH Orphazyme
$7.12 /

-7.43 (-51.07%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.